Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache These guidelines, were developed by the American Academy of Family Physicians and the American College of Physicians–American Society of Internal Medicine, with assistance from the American Headache Society. The target audience for this guideline is primary care physicians. The guideline applies to patients with acute migraine attacks, with or without aura, and patients with migraine who are candidates for preventive drug therapy
American College of Physicians–American Society of Internal Medicine: Pharmacologic Treatment of Acute Major Depression and Dysthymia This guideline is based on an evidence report on pharmacotherapies for depression that was commissioned
by the Agency for Healthcare Research and Quality. It answers the following questions: What is the evidence supporting the benefits of pharmacologic treatment? What are the data on the efficacy and side effect profiles of “newer” compared with “older” pharmacotherapies? How can the evidence assist physicians and patients in making informed decisions about treatment options?
Principles of Appropriate Antibiotic Use for Treatment of Acute Respiratory Tract Infections in Adults: Background, Specific Aims, and Methods The CDC convened a panel of physicians representing the disciplines of internal medicine, family medicine, emergency medicine, and infectious diseases to develop principles provide evidence-based recommendations for evaluation and treatment of adults with acute respiratory illnesses. The goal of the principles is to provide clinicians with practical strategies for limiting antibiotic use to the patients who are most likely to benefit from it.
